EMERYVILLE, Calif., June 07, 2021 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, today announced that Andrew Allen, M.D., Ph.D., co-founder, president and chief executive officer, will present a company overview at the Goldman Sachs 42nd Annual Global Healthcare Conference on Thursday, June 10, 2021, at 10:30 a.m. ET.

By A Silva